Literature DB >> 8659700

Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.

H Miyakawa1, N Izumi, F Marumo, C Sato.   

Abstract

To assess the interaction of alcohol, hepatitis C virus (HCV), and hepatitis B virus (HBV) infection in hepatocarcinogenesis, we prospectively observed 449 patients with liver cirrhosis (LC) who presented to our outpatient clinics in 1 month; 164 patients with habitual drinking [alcoholic liver-liver cirrhosis (AL-LC)] who had taken > 72 g alcohol/day (HCV-positive 81 cases: HCV + AL; HCV-negative 83 cases: AL); 176 patients with HCV infection, but without alcohol intake: 34 patients with HBV infection: 6 patients with HCV and HBV coinfection; and 82 patients with liver diseases from other etiologies, such as primary biliary cirrhosis. In the HCV group, the cumulative occurrence rate of hepatocellular carcinoma (HCC) was 9%, 18%, and 23% in the first, second, and third years, respectively. In the HCV + AL group, that was 13%, 17%, and 28%, respectively. There was no difference in the HCC occurrence rate between the two groups. In the AL group, the cumulative HCC occurrence rate was only 1% during the observation period of 3 years. The occurrence rate was significantly lower in the AL group, compared with the HCV and the HCV + AL groups. In the HBV group, the cumulative occurrence rate of HCC during the observation period of 3 years was 17%, which was similar to that of the HBV + AL group, 14%. We also examined some other variables that might be related to the development of HCC. The cumulative occurrence rate of HCC in male patients was 31%, whereas that was 18% in female patients. In the HCV group, there was a significant increase of HCC occurrence rate in male patients. In contrast, no difference was observed in the HCC occurrence rate between male and female patients in the HBV group. The present study suggests that alcohol alone may not be an independent risk factor for HCC, nor does it accelerate HCC development in LC patients with HCV and HBV infection during the prospective observation of 3 years.

Entities:  

Mesh:

Year:  1996        PMID: 8659700     DOI: 10.1111/j.1530-0277.1996.tb01738.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  5 in total

1.  Can propranalol prevent hepatocellular carcinoma?

Authors:  W Thomas London; Katherine A McGlynn
Journal:  Cancer Prev Res (Phila)       Date:  2012-08

2.  Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study.

Authors:  Oh Sang Kwon; Young Kul Jung; Yun Soo Kim; Sang Gyune Kim; Young Seok Kim; Jung Il Lee; Jin Woo Lee; Young Soo Kim; Byung Chul Chun; Ju Hyun Kim
Journal:  Korean J Hepatol       Date:  2010-09

Review 3.  Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma.

Authors:  Patrizia Burra; Alberto Zanetto; Giacomo Germani
Journal:  Cancers (Basel)       Date:  2018-02-09       Impact factor: 6.639

4.  [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

Authors:  M A Kern; K Breuhahn; M Schuchmann; P Schirmacher
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

5.  A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

Authors:  S A McDonald; S J Hutchinson; S M Bird; C Robertson; P R Mills; J F Dillon; D J Goldberg
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.